Aldeyra Therapeutics, Inc.
COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE

Last updated:

Abstract:

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.

Status:
Application
Type:

Utility

Filling date:

1 Feb 2021

Issue date:

2 Sep 2021